A groundbreaking brain implant, developed through a remarkable interdisciplinary collaboration between Columbia University, NewYork-Presbyterian Hospital, Stanford University, and the University of Pennsylvania, promises to fundamentally transform human-computer interaction and unlock unprecedented therapeutic avenues for a spectrum of neurological conditions. This minimally invasive, high-throughput brain-computer interface (BCI), dubbed the Biological Interface System to Cortex (BISC), boasts an extraordinarily small size and an unparalleled capacity for high-speed data transmission, offering a paradigm shift in our ability to communicate with and understand the brain. Its potential applications span from advanced seizure control in epilepsy to the restoration of motor, speech, and visual functions in individuals affected by spinal cord injuries, ALS, stroke, and blindness.

The core innovation of BISC lies in its singular silicon chip design, a departure from the bulky, multi-component implants that have characterized previous BCI technologies. This integrated circuit acts as a wireless, high-bandwidth bridge between the brain and external computing systems. The intricate architecture of BISC, detailed in a recent publication in Nature Electronics, comprises the ultra-thin chip implant, a wearable external "relay station," and the sophisticated software required to operate the entire platform. Ken Shepard, a leading figure in electrical engineering, biomedical engineering, and neurological sciences at Columbia University and a senior author on the study, highlighted the dramatic miniaturization achieved by BISC. "Most implantable systems are built around a canister of electronics that occupies enormous volumes of space inside the body," Shepard explained. "Our implant is a single integrated circuit chip that is so thin that it can slide into the space between the brain and the skull, resting on the brain like a piece of wet tissue paper." This ingenious design minimizes invasiveness, reduces the risk of tissue damage, and allows for a far more natural integration with the delicate brain tissue.

Andreas S. Tolias, PhD, a professor at the Byers Eye Institute at Stanford University and co-founding director of the Enigma Project, brought his extensive expertise in training AI systems on large-scale neural recordings to the project. His collaboration was instrumental in evaluating BISC’s capacity to decode brain activity. Tolias emphasized the transformative potential of BISC, stating, "BISC turns the cortical surface into an effective portal, delivering high-bandwidth, minimally invasive read-write communication with AI and external devices. Its single-chip scalability paves the way for adaptive neuroprosthetics and brain-AI interfaces to treat many neuropsychiatric disorders, such as epilepsy." This ability to establish a high-bandwidth link with the brain opens up new possibilities for real-time data acquisition and manipulation, crucial for both understanding and intervening in complex neurological processes.

The clinical perspective was spearheaded by Dr. Brett Youngerman, an assistant professor of neurological surgery at Columbia University and a neurosurgeon at NewYork-Presbyterian/Columbia University Irving Medical Center. Dr. Youngerman, who served as the project’s main clinical collaborator, expressed immense optimism about the device’s capabilities. "This high-resolution, high-data-throughput device has the potential to revolutionize the management of neurological conditions from epilepsy to paralysis," he asserted. The team, including Youngerman, Shepard, and Dr. Catherine Schevon, an epilepsy neurologist at NewYork-Presbyterian/Columbia, has already secured a significant National Institutes of Health grant to explore BISC’s application in treating drug-resistant epilepsy. "The key to effective brain-computer interface devices is to maximize the information flow to and from the brain, while making the device as minimally invasive in its surgical implantation as possible. BISC surpasses previous technology on both fronts," Youngerman added, underscoring the dual advantages of BISC in terms of data capacity and surgical ease.

Shepard further elucidated the impact of advancements in semiconductor technology on the development of BISC. "Semiconductor technology has made this possible, allowing the computing power of room-sized computers to now fit in your pocket," he noted. "We are now doing the same for medical implantables, allowing complex electronics to exist in the body while taking up almost no space." This remarkable feat of miniaturization is a direct consequence of leveraging cutting-edge semiconductor fabrication techniques.

Traditional medical-grade BCIs typically involve multiple discrete microelectronic components, such as amplifiers, data converters, and radio transmitters, all housed within a relatively large implanted canister. This canister often requires extensive surgical procedures for implantation, either by removing a portion of the skull or placing it elsewhere in the body, with wires extending to the brain. BISC, in stark contrast, integrates all these essential functions onto a single complementary metal-oxide-semiconductor (CMOS) integrated circuit. This chip has been thinned to an astonishing 50 micrometers and occupies less than 1/1000th the volume of a standard implant, with a total volume of approximately 3 mm³. Its flexible nature allows it to conform to the curvature of the brain’s surface. This micro-electrocorticography (µECoG) device is equipped with an impressive 65,536 electrodes, enabling 1,024 recording channels and 16,384 stimulation channels. Crucially, the chip’s production utilizes established semiconductor industry manufacturing methods, making it amenable to large-scale, cost-effective production.

The integrated chip encompasses a radio transceiver, a wireless power circuit, digital control electronics, power management systems, data converters, and the analog components necessary for both recording and stimulation. The external relay station, a wearable component, provides both power and data communication via a custom ultrawideband radio link that achieves an impressive 100 Mbps throughput – a rate at least 100 times faster than any other wireless BCI currently available. Operating as an 802.11 WiFi device, the relay station seamlessly connects the implant to any external computer. BISC also incorporates its own dedicated instruction set and a comprehensive software environment, effectively creating a specialized computing system tailored for brain interfaces. The high-bandwidth recording capabilities demonstrated by BISC are crucial for enabling the processing of brain signals by advanced machine-learning and deep-learning algorithms, which are capable of interpreting complex intentions, perceptual experiences, and brain states with unprecedented accuracy. "By integrating everything on one piece of silicon, we’ve shown how brain interfaces can become smaller, safer, and dramatically more powerful," Shepard concluded.

The advanced semiconductor fabrication process employed for the BISC implant utilizes TSMC’s 0.13-µm Bipolar-CMOS-DMOS (BCD) technology. This sophisticated method merges three distinct semiconductor technologies onto a single chip, facilitating the creation of mixed-signal integrated circuits (ICs). This integration allows for the efficient co-existence of digital logic (from CMOS), high-current and high-voltage analog functions (from bipolar and DMOS transistors), and power devices (from DMOS) – all critical for BISC’s exceptional performance.

The transition of BISC from the laboratory to clinical application is being actively pursued through a close partnership between Shepard’s group and Youngerman at NewYork-Presbyterian/Columbia University Irving Medical Center. They have successfully developed and refined surgical procedures for safely implanting the ultra-thin device in preclinical models, confirming its ability to produce high-quality, stable neural recordings. Short-term intraoperative studies in human patients are already underway, providing invaluable real-world data. "These initial studies give us invaluable data about how the device performs in a real surgical setting," Youngerman stated. "The implants can be inserted through a minimally invasive incision in the skull and slid directly onto the surface of the brain in the subdural space. The paper-thin form factor and lack of brain-penetrating electrodes or wires tethering the implant to the skull minimize tissue reactivity and signal degradation over time."

Extensive preclinical research in the motor and visual cortices was conducted in collaboration with Dr. Tolias and Bijan Pesaran, a professor of neurosurgery at the University of Pennsylvania, both renowned leaders in computational and systems neuroscience. Pesaran highlighted the profound implications of BISC’s miniaturization: "The extreme miniaturization by BISC is very exciting as a platform for new generations of implantable technologies that also interface with the brain with other modalities such as light and sound." The development of BISC was facilitated by the Defense Advanced Research Projects Agency’s (DARPA) Neural Engineering System Design program, leveraging Columbia’s extensive expertise in microelectronics, the cutting-edge neuroscience programs at Stanford and Penn, and the surgical prowess of NewYork-Presbyterian/Columbia University Irving Medical Center.

To accelerate the path towards commercialization and widespread clinical use, researchers from Columbia and Stanford have established Kampto Neurotech, a startup founded by Dr. Nanyu Zeng, a lead engineer on the project and a Columbia electrical engineering alumnus. This company is actively producing research-ready versions of the BISC chip and is focused on securing the necessary funding to prepare the system for human patient trials. "This is a fundamentally different way of building BCI devices," Zeng remarked. "In this way, BISC has technological capabilities that exceed those of competing devices by many orders of magnitude." As artificial intelligence continues its rapid advancement, BCIs are increasingly recognized for their dual potential: restoring lost neurological functions and, in the future, potentially enhancing normal human capabilities through direct brain-to-computer communication. "By combining ultra-high resolution neural recording with fully wireless operation, and pairing that with advanced decoding and stimulation algorithms, we are moving toward a future where the brain and AI systems can interact seamlessly — not just for research, but for human benefit," Shepard concluded. "This could change how we treat brain disorders, how we interface with machines, and ultimately how humans engage with AI."